TP53 is one of the most frequently mutated genes in all cancers and is mutated in 70% of pancreatic cancers [23], mostly resulting in the loss of DNA binding ability and thus subsequently gene transcription activation [24] (Figure 2, Table 1). This evidence concerns the gene TP53 and pancreatic neoplasm.